← Comparing 1 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Cell-Type-Specific TFEB Modulation Combined with Trehalose f (TFEB) — 0.00 Alpha-theta entrainment therapy to enhance default mode netw (SST) — 0.00 GLUT1-Mediated Carrier-Conjugate Delivery Strategy (LDLR) — 0.00 TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Stra (LDLR) — 0.00 LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy (LAMP2A) — 0.00 Closed-loop transcranial focused ultrasound with gamma entra (PVALB) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 Closed-loop transcranial focused ultrasound to restore hippo (SST) — 0.00 LAMP1 Overexpression to Enhance Lysosomal Capacity Independe (LAMP1) — 0.00 eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 LDLR-Mediated Neurosteroid Precursor Delivery Strategy (LDLR) — 0.00 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.97 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Cortico-Striatal Synchrony Restoration via NMDA Modulation (GRIN2B) — 0.95 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Rece (MAPT) — 0.94 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.92 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.90 APOE-Dependent Autophagy Restoration (MTOR) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89
Add
|
× GLE1-Mediated mRNA Export
GLE1,DBP10,EXPORTIN-1,XPO1,mRNA export machinery,NPC · als · mechanistic
Composite 0.823
Price $0.73
Evidence For 0
Evidence Against 0
GLE1 (Gle1) is an essential mRNA export factor that functions at the nuclear pore complex (NPC) cytoplasmic face, mediating the release of mRNA export complexes into the cytoplasm. This hypothesis proposes that ALS-linked GLE1 mutations (p.R392X, p.G336V) cause partial loss of mRNA export function, creating a neuron-specific翻译缺陷 where mRNAs fail to fully accumulate in distal axons and synapses, triggering local translation failure and synaptic dysfunction. The mechanistic prediction is that moto
Radar Chart — 10 Dimensions
Score Breakdown
Dimension GLE1-Mediated mRNA Export Defe Mechanistic 0.760 Evidence 0.750 Novelty 0.820 Feasibility 0.680 Impact 0.780 Druggability 0.000 Safety 0.000 Competition 0.000 Data 0.000 Reproducible 0.000 KG Connect 0.500
Evidence GLE1-Mediated mRNA Export Defect Creates Translation-Compete No evidence citations yet
Price History Overlay